AI-ECG Tracker vs DeepTek CXR Analyzer
AI Verdict
Choose AI-ECG Tracker if…
Choose the AI-ECG Tracker if your primary need is rapid, highly accurate AI-powered auto-diagnosis of 12-lead ECGs for specific cardiac abnormalities like arrhythmias, myocardial ischemia, or infarction. This tool is ideal for clinical settings requiring immediate, precise ECG interpretation to support cardiologists and emergency medicine practitioners, leveraging its dedicated on-premise workstation for fast processing.
View AI-ECG Tracker →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if your goal is to enhance the efficiency and accuracy of chest X-ray interpretation by leveraging AI-powered computer-assisted detection for a wide range of lung, pleural, and cardiac pathologies. This solution is best suited for radiology departments aiming to significantly reduce radiologist workload and boost productivity through automated identification and categorization of suspicious regions in X-ray scans.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Unknown | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer (Tool B) emphasizes seamless DICOM-based PACS integration and generates secondary capture DICOM with AI output, suggesting a design that fits smoothly into existing radiology workflows. This focus directly aims to reduce radiologist workload and boost productivity, indicating a highly user-friendly experience within a clinical setting. While AI-ECG Tracker (Tool A) offers a rapid diagnosis time, its multi-component setup (workstation, client, web portal) might imply a more fragmented user interaction compared to Tool B's integrated approach.
Clinical Value
AI-ECG TrackerAI-ECG Tracker (Tool A) provides specific, quantifiable clinical validation, stating over 95% accuracy for common cardiac abnormalities and supporting 104 ECG diagnostic classifications. This level of detail offers a strong indicator of its clinical efficacy and comprehensive diagnostic capabilities in cardiology. DeepTek CXR Analyzer (Tool B) is FDA-cleared and aims to improve diagnostic accuracy, but the provided information does not include specific accuracy percentages for its detections, making Tool A's claims more compelling in this dimension.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer (Tool B) offers a transparent 'pay-per-use' pricing model and is available as a technology offering or an AI-assisted reporting service, providing flexibility and clarity on how costs are structured. In contrast, AI-ECG Tracker (Tool A) has no publicly available pricing information for its enterprise solution, making it impossible to assess its value proposition. The transparency of Tool B's pricing model gives it a distinct advantage.
Enterprise Readiness
DeepTek CXR AnalyzerDeepTek CXR Analyzer (Tool B) explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial requirements for enterprise adoption in the US healthcare market. Both tools are FDA-cleared and offer flexible deployment options (on-premise and cloud). However, Tool A's compliance claims are stated as 'likely' rather than explicitly confirmed for the product, giving Tool B a slight edge in demonstrating readiness for stringent enterprise data security and privacy standards.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains by applying AI to complex diagnostic challenges. AI-ECG Tracker (Tool A) is a pioneer in AI-powered ECG auto-diagnosis, offering high accuracy and comprehensive classification for 104 ECG diagnostic types. DeepTek CXR Analyzer (Tool B) innovates by providing an FDA-cleared CADe solution for chest X-rays, detecting 28 findings across multiple pathologies and significantly improving radiologist workflow efficiency. Both represent advanced applications of AI to enhance medical diagnostics.
Support & Docs
DeepTek CXR AnalyzerDeepTek CXR Analyzer (Tool B) clearly outlines a 'Resources Hub' on its website, including a 'Knowledge Base,' and mentions offering support from '140+ Experts delivering 24x7 services'. Furthermore, its FDA documentation indicates that the AI output includes a link to the user manual. While AI-ECG Tracker (Tool A) provides general company contact information, it does not detail a comparable comprehensive suite of support resources or explicit documentation availability for its enterprise product in the provided facts or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | DeepTek CXR Analyzer |
|---|---|---|
| Product Name | AI-ECG Tracker | DeepTek CXR Analyzer |
| Company | Shenzhen Carewell Electronics Co. | DeepTek Medical Imaging Pvt |
| Primary Medical Imaging Modality | ECG data | Chest X-ray |
| Key AI Analysis/Detections | AI-powered ECG auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications (arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction). | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, detecting 28 findings covering lung, pleural, cardiac pathologies, and hardware. Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs). |
| Workflow Impact/Benefit | Rapid diagnosis in approximately 3 seconds. | Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x. Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'. |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and DeepTek CXR Analyzer.